RBLX Financial Statements & Analysis
Complete financial statements for RBLX including income statement, balance sheet, and cash flow statement. Analyze RBLX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
77
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
28.7% ↑
Net Income
18.8% ↑
Gross Margin
1.2% ↑
Operating Margin
34.4% ↑
Balance Sheet
Current Ratio
-5.2% ↓
Debt to Equity
-64.7% ↑
Asset Turnover
10.6% ↑
Cash Flow
Operating Cash Flow
79.5% ↑
Net Cash Flow
101.4% ↑
Free Cash Flow
418.2% ↑
Cash Flow to Debt
75.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.80B | 3.60B | 28.7% | |
| Gross Profit | 2.15B | 2.80B | 30.3% | |
| Operating Income | -1259067000 | -1063317000 | 15.5% | |
| Net Income | -1151946000 | -935384000 | 18.8% | |
| EPS | -1.87 | -1.4446 | 22.7% | |
| EBITDA | -910950000 | -670250000 | 26.4% | |
| Gross Margin | 76.81% | 77.76% | 1.2% | |
| Operating Margin | -44.98% | -29.52% | 34.4% | |
| Net Income Margin | -41.15% | -25.97% | 36.9% | |
| R&D Expenses | 1.25B | 1.44B | 15.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.60B | 2.80B | 2.23B | 1.92B | 923.88M |
| Gross Profit | 2.80B | 2.15B | 1.68B | 1.42B | 683.99M |
| Operating Income | -1063317000 | -1259067000 | -923784000 | -495098000 | -266137000 |
| Net Income | -935384000 | -1151946000 | -924366000 | -491651000 | -253254000 |
| EPS | -1.4446 | -1.87 | -1.55 | -0.97 | -0.47 |
| EBITDA | -670250000 | -910950000 | -761864000 | -421397000 | -220539000 |
| Gross Margin | 77.76% | 76.81% | 75.39% | 74.11% | 74.03% |
| Operating Margin | -29.52% | -44.98% | -41.52% | -25.80% | -28.81% |
| Net Income Margin | -25.97% | -41.15% | -41.54% | -25.62% | -27.41% |
| R&D Expenses | 1.44B | 1.25B | 873.48M | 533.21M | 201.43M |